Dr. Lu Xianping, Founder, Chairman of Chipscreen Biosciences named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards

About this update from Shenzhen Chipscreen Biosciences Co. Ltd. Class A

[{"type":"text","content":"SHENZHEN, China, Dec. 29, 2025 /PRNewswire/ -- On December 5, 2025, Dr. Lu Xianping, Founder, Chairman of Shenzhen Chipscreen Biosciences Co., Ltd, has been named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards.","length":244,"tagName":"p"},{"type":"image","alt":"Dr. Lu Xianping delivers his remarks at the award ceremony.","displaySize":"","headline":null,"caption":"Dr. Lu Xianping delivers his remarks at the award ceremony.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/a3807e4bd21bea295c138a03b37c6a02"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WEhcMOwYoBeRy7QFWpmxCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/a3807e4bd21bea295c138a03b37c6a02","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2852336/image_964427_34864756.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This recognition honors his outstanding contributions to advancing new-quality productive forces and driving innovation within the pharmaceutical industry.","length":155,"tagName":"p"},{"type":"text","content":"The award program, themed "Two Decades of Unwavering Strength, Forging Ahead in the New Era," celebrates entrepreneurs who shoulder new-era responsibilities and contribute significantly to national prosperity and social progress.","length":239,"tagName":"p"},{"type":"text","content":"Dr. Lu Xianping stands as a distinguished scientist and entrepreneur in China's innovative pharmaceutical sector. He earned a Ph.D. in Molecular Biology from Peking Union Medical College, pursued postdoctoral research in the U.S., and successfully founded two biopharmaceutical companies. Driven by the mission to "develop affordable innovative drugs for ordinary people," he chose to return to China and established Chipscreen Biosciences in 2001.","length":462,"tagName":"p"},{"type":"text","content":"Against the backdrop of China's historical focus on generic drugs, Dr. Lu dedicated himself to researching first-in-class drugs with entirely novel mechanisms of action. By building a new drug discovery and evaluation platform based on chemical genomics and AI-assisted design, he significantly improved R&D success rates and shorten...

More updates from Shenzhen Chipscreen Biosciences Co. Ltd. Class A